Cryo-Cell International, Inc.
CCEL
$4.70
-$0.1267-2.63%
AMEX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 31.99M | 32.10M | 31.99M | 31.84M | 31.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.99M | 32.10M | 31.99M | 31.84M | 31.64M |
| Cost of Revenue | 7.60M | 7.77M | 7.85M | 11.98M | 12.01M |
| Gross Profit | 24.39M | 24.33M | 24.13M | 19.86M | 19.63M |
| SG&A Expenses | 19.06M | 18.82M | 18.61M | 18.04M | 17.70M |
| Depreciation & Amortization | 772.60K | 642.30K | 483.60K | 568.60K | 655.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.16M | 28.07M | 28.19M | 31.97M | 31.89M |
| Operating Income | 3.83M | 4.03M | 3.80M | -130.60K | -249.50K |
| Income Before Tax | 1.65M | 2.54M | 2.80M | -12.35M | -12.66M |
| Income Tax Expenses | 1.82M | 2.41M | 2.40M | -3.42M | -3.36M |
| Earnings from Continuing Operations | -0.17 | 0.13 | 0.40 | -8.93 | -9.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -171.20K | 128.80K | 402.10K | -8.93M | -9.30M |
| EBIT | 3.83M | 4.03M | 3.80M | -130.60K | -249.50K |
| EBITDA | 4.82M | 4.89M | 4.49M | 650.20K | 623.60K |
| EPS Basic | -0.02 | 0.02 | 0.05 | -1.07 | -1.12 |
| Normalized Basic EPS | 0.12 | 0.16 | 0.16 | -0.06 | -0.05 |
| EPS Diluted | -0.03 | 0.01 | 0.05 | -1.07 | -1.12 |
| Normalized Diluted EPS | 0.12 | 0.16 | 0.15 | -0.07 | -0.05 |
| Average Basic Shares Outstanding | 32.29M | 32.33M | 32.52M | 32.74M | 32.97M |
| Average Diluted Shares Outstanding | 32.57M | 32.67M | 32.80M | 33.02M | 33.19M |
| Dividend Per Share | 0.65 | 0.50 | 0.25 | -- | -- |
| Payout Ratio | -3,067.58% | 3,137.42% | 502.49% | -- | -- |